Gyre Therapeutics (GYRE) Interest Coverage Ratio (2020 - 2024)
Historic Interest Coverage Ratio for Gyre Therapeutics (GYRE) over the last 10 years, with Q1 2024 value amounting to 25.62.
- Gyre Therapeutics' Interest Coverage Ratio rose 14722.52% to 25.62 in Q1 2024 from the same period last year, while for Dec 2024 it was 51.31, marking a year-over-year increase of 14907.49%. This contributed to the annual value of 25.92 for FY2023, which is 48694.61% down from last year.
- Gyre Therapeutics' Interest Coverage Ratio amounted to 25.62 in Q1 2024, which was up 14722.52% from 10.36 recorded in Q1 2023.
- Over the past 5 years, Gyre Therapeutics' Interest Coverage Ratio peaked at 25.62 during Q1 2024, and registered a low of 2300.0 during Q3 2020.
- Over the past 3 years, Gyre Therapeutics' median Interest Coverage Ratio value was 183.23 (recorded in 2020), while the average stood at 660.21.
- Examining YoY changes over the last 5 years, Gyre Therapeutics' Interest Coverage Ratio showed a top increase of 14722.52% in 2024 and a maximum decrease of 14722.52% in 2024.
- Quarter analysis of 3 years shows Gyre Therapeutics' Interest Coverage Ratio stood at 376.82 in 2020, then skyrocketed by 102.75% to 10.36 in 2023, then surged by 147.23% to 25.62 in 2024.
- Its last three reported values are 25.62 in Q1 2024, 10.36 for Q1 2023, and 376.82 during Q4 2020.